U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
185401185401BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's LymphomaCompletedNo Results AvailableLeukemia|LymphomaDrug: BL22 immunotoxin|Procedure: antibody-drug conjugate therapy|Procedure: immunotoxin therapyhttps://ClinicalTrials.gov/show/NCT00126646
185402185402Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerBiological: bevacizumab|Drug: cisplatin|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00126633
185403185403Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: erlotinib hydrochloride|Drug: sorafenib tosylatehttps://ClinicalTrials.gov/show/NCT00126620
185404185404Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland CancerTerminatedNo Results AvailableHigh-grade Salivary Gland Mucoepidermoid Carcinoma|Recurrent Salivary Gland Cancer|Salivary Gland Acinic Cell Tumor|Salivary Gland Adenocarcinoma|Salivary Gland Poorly Differentiated Carcinoma|Stage IVA Salivary Gland Cancer|Stage IVB Salivary Gland CanceBiological: trastuzumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00126607
185405185405Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney CancerCompletedNo Results AvailableClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Renal Cell CancerDrug: Sorafenib Tosylate|Biological: Recombinant Interferon Alfa-2b|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00126594
185406185406Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-Small Cell Lung CancerActive, not recruitingHas ResultsAdenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: erlotinib hydrochloride|Drug: paclitaxel|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT00126581
185407185407Sorafenib in Treating Patients With Advanced Anaplastic Thyroid CancerTerminatedHas ResultsAnaplastic Thyroid Cancer|Recurrent Thyroid CancerDrug: sorafenib tosylatehttps://ClinicalTrials.gov/show/NCT00126568
185408185408Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin CancerCompletedHas ResultsRecurrent Skin Cancer|Squamous Cell Carcinoma of the SkinDrug: Gefitinib|Radiation: Radiotherapy|Procedure: Conventional surgery|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00126555
185409185409Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNo Results AvailableFallopian Tube Cancer|Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial CancerBiological: bevacizumab|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00126542
185410185410Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive DeclineCompletedNo Results AvailableBrain Infarction|HypertensionDrug: Angiotensin II Receptor Antagonists|Drug: Angiotensin-converting Enzyme Inhibitorshttps://ClinicalTrials.gov/show/NCT00126516
185411185411Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney CancerCompletedHas ResultsChromophobe Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Sarcomatoid Renal Cell Carcinoma|Stage IV Renal Cell CancerBiological: Bevacizumab|Drug: Sorafenib Tosylate|Other: Pharmacological Study|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00126503
185412185412Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedHas ResultsRecurrent Renal Cell Carcinoma|Stage IV Renal Cell CancerBiological: Aldesleukin|Biological: Bevacizumab|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00126490
185413185413Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic CancerCompletedNo Results AvailableLeukemia|Lymphoma|Myelodysplastic Syndromes|Quality of LifeProcedure: cognitive assessment|Procedure: management of therapy complications|Procedure: psychosocial assessment and care|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00126477
185414185414Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the BreastActive, not recruitingNo Results AvailableBreast CancerDrug: fulvestrant|Drug: tamoxifen citrate|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00126464
185415185415A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)TerminatedNo Results AvailableBreast Cancer|Colorectal Cancer|Non-small-cell Lung CarcinomaDrug: MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA)|Drug: Duration of Treatment - During each treatment cycle, treatment is administered twice daily for 14 days, followed by 7 days of rest for a total of 10 cycleshttps://ClinicalTrials.gov/show/NCT00126451
185416185416Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedNo Results AvailableHeart Failure, CongestiveDrug: 123I-mIBG (meta-iodobenzylguanidine)https://ClinicalTrials.gov/show/NCT00126438
185417185417Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedNo Results AvailableHeart Failure, CongestiveDrug: 123I-mIBG (meta-iodobenzylguanidine)https://ClinicalTrials.gov/show/NCT00126425
185418185418Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or NeuroblastomaCompletedNo Results AvailablePheochromocytoma|NeuroblastomaDrug: 123I-mIBG (meta-iodobenzylguanidine)https://ClinicalTrials.gov/show/NCT00126412
185419185419A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of RosaceaCompletedNo Results AvailableRosaceaDrug: doxycyclinehttps://ClinicalTrials.gov/show/NCT00126399
185420185420Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the CommunityCompletedNo Results AvailableCancer|Hypercalcemia|PainDrug: Zoledronic acid (Zometa)https://ClinicalTrials.gov/show/NCT00126386
185421185421A Trial of Wellbutrin for Crohn's DiseaseCompletedNo Results AvailableCrohn DiseaseDrug: Wellbutrin (bupropion)https://ClinicalTrials.gov/show/NCT00126373
185422185422STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)RecruitingNo Results AvailableBreast CancerDrug: Timing of Anastrozole in respect to radiotherapyhttps://ClinicalTrials.gov/show/NCT00126360
185423185423Effect of Betaine, Serine and Folic Acid on Vascular Function in Healthy VolunteersCompletedNo Results AvailableHealthy|Cardiovascular DiseasesProcedure: supplementation with betaine, serine, and folic acidhttps://ClinicalTrials.gov/show/NCT00126347
185424185424Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT PilotCompletedNo Results AvailableMyocardial Infarction|AnemiaProcedure: Packed Red Blood Cell Transfusionhttps://ClinicalTrials.gov/show/NCT00126334
185425185425Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)RecruitingNo Results AvailableLeukemia, Myelocytic, AcuteDrug: cladribinehttps://ClinicalTrials.gov/show/NCT00126321
185426185426Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial LipoatrophyTerminatedNo Results AvailableHIV-Associated Lipodystrophy|HIV InfectionsDevice: poly-L-lactic acid|Device: poly-L-lactic acidhttps://ClinicalTrials.gov/show/NCT00126308
185427185427Evaluation of an Individualised Written Education Package for Stroke PatientsCompletedNo Results AvailableStrokeDevice: 'What you need to know about stroke' education packagehttps://ClinicalTrials.gov/show/NCT00126295
185428185428A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive DisorderCompletedNo Results AvailableObsessive-Compulsive DisorderBehavioral: behavior therapy|Drug: D-Cycloserinehttps://ClinicalTrials.gov/show/NCT00126282
185429185429Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown PrimaryRecruitingNo Results AvailableCarcinomaDrug: cisplatin|Drug: gemcitabinehttps://ClinicalTrials.gov/show/NCT00126269
185430185430Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal CancerCompletedNo Results AvailableColorectal Cancer|MetastasisDrug: 5-fluorouracil|Drug: leucovorin|Drug: irinotecan|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00126256

* Görseller ve İçerik tekif hakkına sahip olabilir